Treace Medical Concepts Inc (TMCI) Q3 2026 Earnings Call Highlights: Revenue Slips 4% but ...
Treace Medical Concepts Inc (TMCI) posted a 4% revenue decline to $48.3 million in Q3 2026, yet cut operating expenses 10% and swung to positive adjusted EBITDA while narrowing full-year guidance. Related Stocks: TMCI ,